OBLIQUE THERAPEUTICS
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.
OBLIQUE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Hospital Medical Pharmaceutical
Founded:
2015-01-01
Address:
Göteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.obliquet.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Sitelinks Search Box Euro Organization Schema
Current Employees Featured
Founder
Investors List
Almi Invest
Almi Invest investment in Venture Round - Oblique Therapeutics
Official Site Inspections
http://www.obliquet.com Semrush global rank: 9.07 M Semrush visits lastest month: 220
- Host name: tenjin.oderland.com
- IP address: 91.201.60.13
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Oblique Therapeutics"
Board of Directors and Management - Oblique
Born 1971. PhD in biomedical research from University of Copenhagen and did his post-doctoral training at Institute Pasteur in Paris. Started as board member of Oblique Therapeutics AB 2023.See details»
Oblique Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early …See details»
Oblique Therapeutics AB (publ.) - LinkedIn
Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer.See details»
We are hiring- Laboratory Engineer - Oblique
· Assist other scientists within the organization and be introduced to new techniques depending on your own interests and the company’s needs. Qualifications. Key qualifications are: ... Send …See details»
Oblique Therapeutics AB (publ.)’s Post - LinkedIn
Søren stands as an independent force within our organization, ensuring transparent decision-making processes. We value his contributions to Oblique Therapeutics AB's mission.See details»
Oblique Therapeutics - Overview, News & Similar companies
Nov 9, 2022 Who is Oblique Therapeutics. Oblique Therapeutics AB is a privately held Swedish biotech company developing innovative new medicines for severe diseases with a large unmet …See details»
Oblique - Sunstone
Oblique Therapeutics. Oblique Therapeutics AB (Gothenburg, Sweden) holds a novel antibody platform that allows the identification of new therapeutic antibodies towards targets that cannot …See details»
Oblique Therapeutics AB (publ.) Overview - SignalHire
Organization Website: obliquet.com : Oblique Therapeutics... industries Pharma, Biotechnology: Headquarters Location: Arvid Wallgrens Backe 20, Göteborg, Västra Götalands Län, 413 46 …See details»
Oblique Therapeutics AB (publ.) Information - RocketReach
Obliquet.com; View Similar People. Related Companies RaceONE. 9 $5m Learn More How It Works. Get a Free Account. Sign up for a free account. No credit card required. Up to 5 free …See details»
Oblique Therapeutics announces an agreement with leading …
Oblique Therapeutics has entered into an agreement with a leading animal health company to apply the AbiProt® technology to generate antibodies to a high-value target.See details»
Oblique Therapeutics - Craft
Oblique Therapeutics has 5 employees across 2 locations and $2.5 m in total funding,. See insights on Oblique Therapeutics including office locations, competitors, revenue, financials, …See details»
Oblique Therapeutics AB (publ.) Company Overview, Contact …
Dec 11, 2015 Oblique Therapeutics AB partnered with Targovax on Jun 29th '20. Oblique Therapeutics today announces that it has entered into a collaboration agreement with …See details»
Oblique Therapeutics and the KTH Royal Institute of Technology …
STOCKHOLM, June 18, 2024 /PRNewswire/ -- Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce …See details»
Oblique Therapeutics AB (publ.)’s Post - LinkedIn
[CONGRESS] - Today starts the Drug Discovery Nexus event with Sreesha Srinivasa our Chief Development Officer as Keynote Speaker. Looking forward this rich…See details»
Oblique Therapeutics idea and vision.
Asset-generation through our game-changing antibody platform. We are driven by curiosity and innovation to develop a solid portfolio based on asset-generation through our game-changing …See details»
Oblique Therapeutics is delighted to announce the appointment …
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large …See details»
Org Chart Creator: Free Organizational Chart Maker
Customizable Bricks Free Org Chart Creator. Create your org chart in seconds. Say goodbye to manual chart creation. Just copy-paste or import names, titles, managers, and even images — …See details»
Archives: News - Oblique
Jan 15, 2024 August 22, 2024 News. Oblique Therapeutics enters a research agreement with Eli Lilly and Company. Stockholm, Sweden - August 22, 2024 - Oblique Therapeutics, a leading …See details»
ANNUAL GENERAL MEETING 2022 - Oblique
Skicka din fråga, komplett med ditt namn och dina kontaktuppgifter, till [email protected] senast den 5 juni 2022. Bolaget kommer, om styrelsen anser att …See details»